Table 2 Compliance loss thresholds for various price levels of generic risperidone at which staying on branded risperidone is cost-effective and dominant
Price reduction for generic risperidone (compared to branded price) | Min. compl. loss† for cost-effectiveness* | Min. compl. loss† for dominance |
|---|---|---|
20% | 2.8% | 3.7% |
30% | 4.1% | 5.5% |
40% | 5.2% | 6.9% |
50% | 6.7% | 8.8% |
60% | 7.9% | 10.5% |